Aug 20 2024
A new study conducted by researchers at Suleyman Demirel University in Türkiye has found that cannabidiol (CBD), a compound derived from cannabis, may significantly enhance the effectiveness of the chemotherapy drug etoposide in treating prostate cancer. Published in the US National Library of Medicine, the study suggests that CBD could play a vital role in …
Aug 19 2024
A new study reveals a link between marijuana use and lower obesity rates among U.S. adults. The study, published in the peer reviewed journal Cannabis and Cannabinoid Research and the U.S. National Library of Medicine, was conducted by Brigham Young University researchers. The study analyzed data from the Behavioral Risk Factor Surveillance System, which surveyed 735,921 …
Aug 17 2024
A new study published in the journal Psychopharmacology shows that cannabidiol (CBD) may be useful as a sleep aid for individuals suffering from insomnia. Conducted by researchers from Swinburne University of Technology and the Institute for Breathing and Sleep at Austin Hospital, the randomized controlled pilot trial explored whether nightly use of CBD impacts daytime …
Aug 16 2024
A new study published in the Journal of Clinical Oncology reveals that marijuana capsules containing both tetrahydrocannabinol (THC) and cannabidiol (CBD) significantly reduces chemotherapy-induced nausea and vomiting in patients who have not responded to standard antiemetic treatments. This randomized, placebo-controlled, phase II/III trial, conducted across 19 hospitals and universities in Australia, is one of the …
Aug 15 2024
A study published in the latest issue of the journal Pharmaceutics indicates that cannabinoids may be useful in treating periodontal disease. Titled The Role of Different Types of Cannabinoids in Periodontal Disease: An Integrative Review, the study explores the involvement of cannabinoid receptors in both healthy and inflamed periodontal tissues. In addition to the journal …
Aug 14 2024
The University of California, San Francisco (UCSF) is actively recruiting participants for three clinical trials exploring the effects of psilocybin on various mental health conditions, including Alzheimer’s disease and depressions/anxiety associated with advanced cancer. The first study, titled “Psilocybin for Depression and Anxiety in Patients With Advanced Cancer“, will investigate the potential of psilocybin to …
Aug 13 2024
A new study set to be published in the October 2024 issue of The Journal of Nurse Practitioners finds that medical cannabis can significantly improve the quality of life for patients suffering from anxiety, depression, insomnia, and chronic pain. Conducted at a medical cannabis clinic in rural Appalachia, Virginia, by researchers from Old Dominion University, …
Aug 12 2024
In 2024, a growing body of research has highlighted the potential therapeutic benefits of psilocybin, the psychedelic compound found in “magic mushrooms”. These studies, published in various peer-reviewed journals, have explored psilocybin’s effects on mental health conditions such as depression, anxiety, obsessive-compulsive disorder (OCD), and even Alzheimer’s disease, among other ailments. With that in mind, …
Aug 09 2024
A recent study published in Pharmacological Reports by researchers at the Medical University of Warsaw suggests that psilocybin may offer significant benefits in treating obsessive-compulsive disorder (OCD). OCD is a chronic mental health condition that affects approximately 2% of the population, characterized by persistent and intrusive thoughts (obsessions) and repetitive behaviors (compulsions) that can severely …
Aug 08 2024
According to a study published in the Archives of Medical Sciences: Atherosclerotic Disease, heart attack patients with a history of marijuana use have a lower in-hospital mortality rate compared to those without a history of use. For the study, researchers from various institutions, including the Detroit Medical Center-Wayne State University and the Royal Devon University …
